Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) Completed Phase 4 Trials for Flu caused by Influenza Prevention

Indications	Status	Purpose	Phase
DBCOND0021701 (Flu caused by Influenza)	Completed	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT00735475	A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine	Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated) (DB10791) Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) (DB11041) Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) (DB14445) Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (propiolactone inactivated) (DB11043) Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) (DB10794) Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) (DB11044)